•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
•
HEALWELL AI Inc. (TSX: AIDX) (OTCQX: HWAIF) has appointed Brad Porter to its Board of Directors, effective immediately. The healthcare artificial intelligence company, focused on preventative care, said Porter will bring extensive experience in finance, commercial leadership, and global healthcare technology.
Brad Porter is Chief Commercial Officer of HEALWELL and CEO of Orion Health. The company said he has more than 15 years of experience across finance and commercial leadership, and is a Chartered Accountant by training. Prior to his current roles, Porter held senior commercial positions at Fisher & Paykel Healthcare and led Orion Health as CEO, driving innovation in health data platforms and AI-enabled care.
At HEALWELL, Porter oversees group-wide commercial strategy, revenue growth, and go-to-market alignment, with a focus on public sector opportunities and government contracts.
HEALWELL also announced that Ian McCrae has stepped down from the Board to focus on other ventures following the successful integration of Orion Health into HEALWELL. The company said McCrae founded Orion Health and built it over more than three decades into a global health information technology company operating across 12 countries.
“We are pleased to welcome Brad Porter to HEALWELL's Board of Directors,” said Hamed Shahbazi, Chair of HEALWELL AI. “Brad brings deep commercial expertise and global healthcare experience from his leadership roles at Orion Health and HEALWELL, and his appointment will further strengthen our ability to execute on our growth strategy.”
HEALWELL added: “We also want to extend our sincere thanks to Ian McCrae for his dedicated service on HEALWELL's Board. His guidance, insight, and contributions have been invaluable during a transformative period for the Company, and we wish him all the best in his future endeavors.”
HEALWELL is a healthcare artificial intelligence company focused on preventative care. Its mission is to improve healthcare and save lives through early identification and detection of disease. The company said it is developing and commercializing advanced clinical decision support systems using proprietary technology to help healthcare providers detect rare and chronic diseases, improve practice efficiency, and improve patient health outcomes.
HEALWELL said it is executing a strategy centered on developing and acquiring technology and clinical sciences capabilities that complement its roadmap. The company is publicly traded on the Toronto Stock Exchange under the symbol AIDX and on the OTC Exchange under the symbol HWAIF.
Premium gym chains are entering a “golden era” that is ending or already in decline, as rising operating costs collide with shifting consumer preferences toward more flexible, community-based ways to exercise. Long-term memberships are shrinking, margins are pressured by higher rents and facility expenses, and competition from smaller, more personalized…
